Perlegen Sciences , Inc.

Industry:	Pharmaceuticals, Biotechnology
Revenues:	$10.1 Million
Employees:	105

Description

Perlegen was founded in 2001 as a spin-out from Affymetrix, a genetic tools company. For the first several years of its existence, until about 2004, Perlegen was focused on re-sequencing 50 human genomes, in order to map out the common elements of genetic diversity. During this time, Perlegen developed a majority of the content now publicly available in the "HapMap," or human haplotype map.

View More Statistics

Site Statistics

Monthly Unique Visitors:	1,053
Site Rank:	1,005,106
Trust Rating:	Neutral
Stats by

News Archive

Perlegen Introduces BREVAGen[TM] Breast Cancer Risk Stratification Test. Business Wire; 9/23/2009 MOUNTAIN VIEW, Calif. -- Perlegen Sciences, which develops genetic tests that correlate genetic variation to disease risk...and its technologies, visit www.perlegen.com. BREVAGen is a trademark of Perlegen Sciences, Inc. ...more

Acologix Hopes To Bring In $115M On Tokyo Exchange. BIOWORLD Today; 11/3/2009 ...raised in an IPO this year on American exchanges. While two companies - Affymax Inc., of Palo Alto, Calif., and Perlegen Sciences Inc., of Mountain View, Calif. - have pending IPOs aimed at raising $115 million, the highest amount raised... ...more

Other News To Note. BIOWORLD Today; 11/3/2009 ...payments. o Affymetrix Inc., of Santa Clara, Calif., said its high-density GeneChip microarrays were used by Perlegen Sciences Inc., of Mountain View, Calif., for studies of the genetic causes of Alzheimer's disease, autism and Parkinson... ...more